0
Original Research |

Effects of Lung Volume Reduction Surgery for Emphysema on Glycolipidic Hormones*

Davide Mineo, MD; Vincenzo Ambrogi, MD; Luca Frasca, MD; Maria Elena Cufari, MD; Eugenio Pompeo, MD; Tommaso Claudio Mineo, MD
Author and Funding Information

*From the Department of Thoracic Surgery, Tor Vergata University Policlinic, Rome, Italy.

Correspondence to: Tommaso Claudio Mineo, MD, Chief, Department of Thoracic Surgery, Tor Vergata University, School of Medicine, Tor Vergata University Policlinic, Viale Oxford, 81, 00133 Rome, Italy; e-mail: mineo@med.uniroma2.it


Chest. 2008;134(1):30-37. doi:10.1378/chest.07-3042
Text Size: A A A
Published online

Background: Pulmonary emphysema is associated with cachexia and disregulation of the hormones regulating the glycolipid metabolism, insulin resistance, and altered substrate utilization. This study aimed at identifying the effects of lung volume reduction surgery (LVRS) on glycolipidic hormones compared to respiratory rehabilitation (RR).

Methods: Thirty-three patients with moderate-to-severe emphysema who were undergoing video-assisted thoracoscopic LVRS were compared to 31 similar patients who refused the operation and followed a standardized RR program. All patients were evaluated before and 12 months after treatment for respiratory function, body composition, glycolipidic hormones, metabolic parameters, and insulin resistance, which was calculated using the homeostatic model assessment index for insulin resistance (HOMA-IR). These groups were compared to a matched healthy control population.

Results: Only after LVRS significant improvements were obtained in respiratory function (FEV1, + 25.2%; p < 0.0001; residual volume, −19.5%; p < 0.0001), metabolic parameters (total cholesterol, + 13.1%; p < 0.01; high-density lipoprotein cholesterol, + 11.2%; p < 0.01; triglycerides, +18.4; p < 0.001; nonesterified fatty acid, − 19.7%; p < 0.001), and body composition (fat-free mass [FFM], + 6.5%; p < 0.01; fat mass [FM], + 11.9%; p < 0.01). The leptin/FM ratio (− 6.1%; p < 0.01) and resistin/FM ratio (− 5.6%; p < 0.01) decreased, whereas the adiponectin/FM ratio (+ 6.9%; p < 0.01) and ghrelin (+ 9.2%; p < 0.01) increased, together with reductions in glycemia (− 8.8%; p < 0.01), insulin level (− 20.4%; p < 0.001), and HOMA-IR (− 27.2%; p < 0.0001). The decrement in residual volume was correlated with increment of FFM (ρ = − 0.49; p < 0.02), FM (ρ = − 0.55; p < 0.009), and ghrelin (ρ = − 0.52; p < 0.01), and also with decreases in leptin corrected for FM (ρ = 0.50; p < 0.02) and, marginally, HOMA-IR (ρ = 0.35; p = 0.07).

Conclusions: After LVRS, glycolipidic hormone levels and nutritional status significantly improved, along with insulin resistance reduction and more physiologic utilization of substrates. Correlations between residual volume and body composition as well as glycolipidic hormone levels suggest that postoperative recovery in respiratory dynamics may induce favorable clinical changes when compared to RR.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543